This course will review the latest treatment modalities in uveitis including the intravitreal delivery systems for long acting and short acting steroids and the various anti-tumor necrosis factor alpha agents. We will compare these new treatments to the currently accepted systemic immunosuppression regimens with steroidal and nonsteroidal immunosuppressive therapy. Updates on infectious uveitis syndromes will be presented. Case presentations with emphasis on audience interaction will provide insight on how to conduct a uveitis work up and how to treat various syndromes.

By Participating, You Will Be Able To:

• Describe the use of immunosuppressive therapy in uveitis patients.
• Describe current clinical trials in ocular inflammatory diseases.
• Identify newer therapies for noninfectious uveitis syndromes.
• Discuss evaluation and treatment of patients with uveitis.

Who Should Attend?

This course is designed for Comprehensive Ophthalmologists, Uveitis and Vitreoretinal Specialists, Optometrists, Internists, Rheumatologists, and Pulmonary Personnel.